Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspFU

Nature

Volumn 454, Issue 7207, 2008, Pages 1009-1013

  Cheng, Hui Chun ^a   Skehan, Brian M ^b   Campellone, Kenneth G ^b   Leong, John M ^b   Rosen, Michael K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BACTERIAL PROTEIN; PROTEIN ESPFU; WISKOTT ALDRICH SYNDROME PROTEIN;

BACTERIUM; CYTOLOGY; CYTOPLASM; ENZYME ACTIVITY; INHIBITION; PROTEIN;

ANIMAL CELL; ARTICLE; ESCHERICHIA COLI; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

ACTINS; AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FIBROBLASTS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; WISKOTT-ALDRICH SYNDROME PROTEIN; WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL;

ESCHERICHIA COLI; EUKARYOTA;

EID: 50049086091     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature07160     Document Type: Article

References (43)

1. U is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. Dev. Cell 7, 217-228 (2004).
2. Garmendia, J. et al. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell. Microbiol. 6, 1167-1183 (2004).
3. Campellone, K. G. et al. Enterohaemorrhagic Escherichia coli Tir requires a C-terminal 12-residue peptide to initiate EspFu-mediated actin assembly and harbours N-terminal sequences that influence pedestal length. Cell. Microbiol. 8, 1488-1503 (2006).
4. Garmendia, J., Carlier, M. F., Egile, C., Didry, D. & Frankel, G. Characterization of TccP-mediated N-WASP activation during enterohaemorrhagic Escherichia coli infection. Cell. Microbiol. 8, 1444-1455 (2006).
5. Lommel, S., Benesch, S., Rohde, M., Wehland, J. & Rottner, K. Enterohaemorrhagic and enteropathogenic Escherichia coli use different mechanisms for actin pedestal formation that converge on N-WASP. Cell. Microbiol. 6, 243-254 (2004).
6. Buck, M., Xu, W. & Rosen, M. K. A two-state allosteric model for autoinhibition rationalizes WASP signal integration and targeting. J. Mol. Biol. 338, 271-285 (2004).
7. Kim, A. S., Kakalis, L. T., Abdul-Manan, N., Liu, G. A. & Rosen, M. K. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 404, 151-158 (2000).
8. Torres, E. & Rosen, M. K. Contingent phosphorylation/ dephosphorylation provides a mechanism of molecular memory in WASP. Mol. Cell 11, 1215-1227 (2003).
9. Munter, S., Way, M. & Frischknecht, F. Signaling during pathogen infection. Sci. STKE 2006, re5 (2006).
10. Caron, E. et al. Subversion of actin dynamics by EPEC and EHEC. Curr. Opin. Microbiol. 9, 40-45 (2006).
11. Hayward, R. D., Leong, J. M., Koronakis, V. & Campellone, K. G. Exploiting pathogenic Escherichia coli to model transmembrane receptor signalling. Nature Rev. Microbiol. 4, 358-370 (2006).
12. Gruenheid, S. & Finlay, B. B. Microbial pathogenesis and cytoskeletal function. Nature 422, 775-781 (2003).
13. Galán, J. E. & Cossart, P. Host-pathogen interactions: a diversity of themes, a variety of molecular machines. Curr. Opin. Microbiol. 8, 1-3 (2005).
14. Rangel, J. M., Sparling, P. H., Crowe, C., Griffin, P. M. & Swerdlow, D. L. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg. Infect. Dis. 11, 603-609 (2005).
15. DeVinney, R. et al. Enterohemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated. Infect. Immun. 67, 2389-2398 (1999).
16. Higgs, H. N. & Pollard, T. D. Regulation of actin filament network formation through Arp2/3 complex: Activation by a diverse array of proteins. Annu. Rev. Biochem. 70, 649-676 (2001).
17. Kelly, A. E., Kranitz, H., Dotsch, V. & Mullins, R. D. Actin binding to the central domain of WASP/Scar proteins plays a critical role in the activation of the Arp2/3 complex. J. Biol. Chem. 281, 10589-10597 (2006).
18. Panchal, S. C., Kaiser, D. A., Torres, E., Pollard, T. D. & Rosen, M. K. A conserved amphipathic helix in WASP/Scar proteins is essential for activation of Arp2/3 complex. Nature Struct. Biol. 10, 591-598 (2003).
19. Rohatgi, R. et al. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97, 221-231 (1999).
20. Buck, M., Xu, W. & Rosen, M. K. Global disruption of the WASP autoinhibited structure on Cdc42 binding. Ligand displacement as a novel method for monitoring amide hydrogen exchange. Biochemistry 40, 14115-14122 (2001).
21. Leung, D. W. & Rosen, M. K. The nucleotide switch in Cdc42 modulates coupling between the GTPase-binding and allosteric equilibria of Wiskott-Aldrich syndrome protein. Proc. Natl Acad. Sci. USA 102, 5685-5690 (2005).
22. Garmendia, J. et al. Distribution of tccP in clinical enterohemorrhagic and enteropathogenic Escherichia coli isolates. J. Clin. Microbiol. 43, 5715-5720 (2005).
23. Alto, N. M. et al. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J. Cell Biol. 178, 1265-1278 (2007).
24. Volkman, B. F., Prehoda, K. E., Scott, J. A., Peterson, F. C. & Lim, W. A. Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell 111, 565-576 (2002).
25. Higgs, H. N., Blanchoin, L. & Pollard, T. D. Influence of the C terminus of Wiskott-Aldrich syndrome protein (WASp) and the Arp2/3 complex on actin polymerization. Biochemistry 38, 15212-15222 (1999).
26. Cooper, J. A. & Pollard, T. D. Methods to measure actin polymerization. Methods Enzymol. 85, 182-210 (1982).
27. Leung, D. W., Morgan, D. M. & Rosen, M. K. Biochemical properties and inhibitors of (N-)WASP. Methods Enzymol. 406, 281-296 (2006).
28. Pace, C. N. Measuring and increasing protein stability. Trends Biotechnol. 8, 93-98 (1990).
29. Campellone, K. G., Giese, A., Tipper, D. J. & Leong, J. M. A tyrosine-phosphorylated 12-amino-acid sequence of enteropathogenic Escherichia coli Tir binds the host adaptor protein Nck and is required for Nck localization to actin pedestals. Mol. Microbiol. 43, 1227-1241 (2002).
30. Rieping, W. et al. ARIA2: automated NOE assignment and data integration in NMR structure calculation. Bioinformatics 23, 381-382 (2007).
31. 2H-labeled proteins. J. Biomol. NMR 13, 369-374 (1999).
32. 1H-δ1 methyl) isoleucine into proteins for multidimensional NMR studies. J. Am. Chem. Soc. 119, 7599-7600 (1997).
33. Clore, G. M. & Gronenborn, A. M. Multidimensional heteronuclear nuclear magnetic resonance of proteins. Methods Enzymol. 239, 349-363 (1994).
34. Muhandiram, D. R. & Kay, L. E. Gradient-enhanced triple-resonance three-dimensional NMR experiments with improved sensitivity. J. Magn. Reson. B 103, 203-216 (1994).
35. 13C-edited nuclear Overhauser enhancement spectroscopy of a protein in solution: application to interleukin 1β. Biochemistry 30, 12-18 (1991).
36. Zwahlen, C. et al. Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy: application to a bacteriophage λ N-peptide/ boxB RNA complex. J. Am. Chem. Soc. 119, 6711-6721 (1997).
37. Cornilescu, G., Delaglio, F. & Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302 (1999).
38. Linge, J. P., Williams, M. A., Spronk, C. A., Bonvin, A. M. & Nilges, M. Refinement of protein structures in explicit solvent. Proteins 50, 496-506 (2003).
39. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293 (1995).
40. Johnson, B. A. & Blevins, R. A. NMR View: A computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603-614 (1994).
41. Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R. & Thornton, J. M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-486 (1996).
42. Carson, M., Charles, W. C. Jr & Robert, M. S. Methods in Enzymology 493-502 (Academic, 1997).
43. DeLano, W. L. The PyMOL User's Manual (DeLano Scientific, 2002).